Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Oragenics Inc is engaged in the healthcare sector. The firm is focused on becoming a leader in developing novel antibiotics against infectious diseases and on developing effective treatments for oral mucositis. Oragenics involves developing its antibiotic product candidate, OG716 as well as other ho... Oragenics Inc is engaged in the healthcare sector. The firm is focused on becoming a leader in developing novel antibiotics against infectious diseases and on developing effective treatments for oral mucositis. Oragenics involves developing its antibiotic product candidate, OG716 as well as other homolog antibiotic product candidates, researching LBPs, and having other product candidates, including SMaRT Replacement Therapy positioned for out-licensing or partnering. It is also developing a Terra CoV-2 immunization product candidate to combat the novel coronavirus. Mehr anzeigen
SARASOTA, Fla., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE: OGEN), a biotechnology company advancing innovative treatments for brain-related health conditions, today announced the...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0246 | 7.55760368664 | 0.3255 | 0.448 | 0.32326 | 4135796 | 0.33888732 | CS |
| 4 | 0.0795 | 29.3791574279 | 0.2706 | 0.448 | 0.2602 | 1289356 | 0.33864782 | CS |
| 12 | -0.0677 | -16.2039253231 | 0.4178 | 0.45 | 0.2542 | 802907 | 0.33968605 | CS |
| 26 | -1.0999 | -75.8551724138 | 1.45 | 2.52 | 0.2542 | 734587 | 0.78191978 | CS |
| 52 | -4.6799 | -93.0397614314 | 5.03 | 7.74 | 0.2542 | 418796 | 0.92783415 | CS |
| 156 | -28.7499 | -98.7969072165 | 29.1 | 35.664 | 0.2542 | 429740 | 14.36480159 | CS |
| 260 | -30.1359 | -98.851604015 | 30.486 | 127.2 | 0.2542 | 3063766 | 49.0949566 | CS |
| Symbol | Preis | Vol. |
|---|---|---|
| SPYSPDR S&P 500 | US$ 591,15 (0,86%) | 122,49M |
| SPXSDirexion Daily S&P 500 Bear 3X Shares New | US$ 6,1628 (-3,25%) | 114,87M |
| SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 27,30 (3,80%) | 108,08M |
| TSLZT Rex 2X Inverse Tesla Daily Target ETF | US$ 2,435 (7,27%) | 94,23M |
| KULRKULR Technology Group Inc | US$ 2,885 (28,79%) | 75,72M |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
